8358 studies found for:    insulin
Show Display Options
Rank Status Study
1 Completed Regulation of Endogenous Glucose Production by Brain Insulin Action
Condition: Insulin Resistance, Diabetes
Interventions: Drug: Intranasal insulin;   Drug: Intranasal placebo
2 Enrolling by invitation Comparison Study of Insulin Glargine and NPH Insulin
Condition: Diabetes
Interventions: Drug: Switching to NPH insulin;   Drug: Continuation of insulin glargine
3 Completed Topic Insulin Accelerates Wound Healing in Diabetes
Conditions: Diabetes Mellitus;   Wounds
Intervention: Drug: topic cream insulin
4 Completed Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Long-acting bedtime insulin detemir (Levemir);   Drug: Insulin detemir and pre-meal insulin aspart.
5 Recruiting Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III
Condition: Diabetes Mellitus
Interventions: Drug: human biphasic insulin;   Drug: human biphasic insulin, reference
6 Completed Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal
Condition: Diabetes Mellitus
Interventions: Drug: Julphar Insulin R (soluble human insulin, biosimilar);   Drug: Huminsulin® Normal (soluble human insulin, reference)
7 Recruiting Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal
Condition: Diabetes Mellitus
Interventions: Drug: Julphar Insulin N (human isophane insulin);   Drug: Huminsulin® Basal (NPH, human isophane insulin)
8 Not yet recruiting Self-management of Type 1 Diabetes Under Functional Insulin Therapy
Conditions: Type 1 Diabetes;   Basal-bolus Multiple-dily Insulin Injections;   Insulin Pump (CSII)
Interventions: Other: Training course to functional insulin therapy;   Other: Usual diabetes management.
9 Recruiting Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
Condition: Type 2 Diabetes
Interventions: Drug: Basal insulin and exenatide;   Drug: Basal insulin only;   Drug: Basal insulin and bolus insulin
10 Recruiting PK/PD STUDY OF U-500 REGULAR INSULIN
Conditions: Type 2 Diabetes;   Insulin Resistance;   High Insulin Requirements
Intervention: Drug: U-500 insulin
11 Enrolling by invitation Insulin Infusion Diabetes Ulcer
Conditions: Diabetes Mellitus;   Insulin Resistance;   Hyperglycemia;   Surgery;   Ulcers;   Infection
Intervention: Procedure: Insulin infusion
12 Not yet recruiting Insulin in Total Parenteral Nutrition
Condition: Diabetes Mellitus
Interventions: Drug: Subcutaneous glargine insulin;   Drug: Regular insulin added to TPN bag
13 Completed
Has Results
Comparison of Insulins Aspart and Lispro in Insulin Pumps
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Insulin Aspart;   Drug: Insulin Lispro
14 Completed Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)
Condition: Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition
Interventions: Drug: Glargine Insulin;   Drug: Regular insulin
15 Completed FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Condition: Type 2 Diabetes
Interventions: Drug: "GLIPULIN:" [insulin glargine, metformin, exenatide (GLP-1-agonist)];   Drug: Insulin glargine, metformin, prandial insulin
16 Completed Insulin Therapy in the Hospital Comparing Two Protocols
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Glargine insulin;   Drug: NPH insulin and regular insulin;   Drug: lispro insulin
17 Unknown  The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
Condition: Diabetes
Interventions: Drug: central insulin;   Drug: Placebo
18 Unknown  Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use
Condition: Insulin-requiring Type 2 Diabetes Mellitus
Interventions: Drug: nph insulin;   Drug: human insulin;   Drug: Insulin Glargine;   Drug: Insulin glulisine
19 Suspended Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Intervention: Drug: Regular Insulin
20 Completed
Has Results
Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro Alone
Condition: Diabetes Mellitus
Interventions: Drug: Insulin Lispro;   Drug: Regular Human Insulin;   Drug: rHuPH20

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years